Company Filing History:
Years Active: 2013
Title: The Innovative Contributions of Mathieu Vokaer
Introduction
Mathieu Vokaer is a notable inventor based in Beersel, Belgium. He has made significant contributions to the field of medical treatments, particularly in evaluating responses to type I interferon therapies. His work is crucial for understanding how individuals respond to treatments for conditions such as multiple sclerosis, hepatitis C virus (HCV), and hepatitis B virus (HBV).
Latest Patents
Mathieu Vokaer holds a patent titled "Method for evaluating the response of an individual to a treatment with a type I interferon." This innovative method describes how to evaluate the in vivo presence of a factor that prevents the biological effect of type I interferon in individuals undergoing treatment. The process involves incubating a blood sample with type I interferon and determining mRNA levels of a biological marker of interferon activity, specifically MxA. This method is essential for assessing the effectiveness of treatments involving type I interferon.
Career Highlights
Throughout his career, Mathieu Vokaer has worked with prestigious institutions, including Université Libre de Bruxelles. His research has focused on the intersection of immunology and therapeutic interventions, contributing to advancements in patient care and treatment efficacy.
Collaborations
Mathieu has collaborated with esteemed colleagues such as Patrick Stordeur and Annick Ocmant. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation in the field.
Conclusion
Mathieu Vokaer's contributions to medical research and his innovative patent demonstrate his commitment to improving treatment methodologies for serious health conditions. His work continues to influence the field and offers hope for better patient outcomes.